Daily non-political popular news in brief.

Clinical trial coordinators need more financial conflict-of-interest training

Medical professionals conducting clinical trials should provide more information about financial conflicts of interest before they talk to patients about participating in the trials.

Read more »

Keywords: clinical, trial, coordinators, financial, conflict-of-interest, training, coordinator, conflict, interest

« Previous | Next »

Similar news on "Clinical trial coordinators need more financial conflict-of-interest training":

1. Is doctors' self-interest endangering the NHS?
   02-05-2007 · EurekAlert!
   Recent newspaper headlines have suggested that doctors' pay is responsible for the financial crisis in the NHS. In this week's BMJ, two experts go head to head over whether the remuneration is justified.Alan Maynard, Professor of Health Economics at York University argues that doctors' self interest manifests itself in two ways: Enhancing personal income and protecting clinical autonomy fiercely -- the right to do what they think is best for their patients.
   Similar news · Read more »
   
2. Multiple myeloma clinical trial shows distinct survival benefit with lower dose of steroids
   12-09-2007 · EurekAlert!
   Results of Eastern Cooperative Oncology Group Phase III clinical trial E4A03, for multiple myeloma, showing significantly better overall survival with lenalidomide plus low-dose dexamethasone therapy compared to lenalidomide plus high-dose dexamethasone, were reported today by S. Vincent Rajkumar, MD, at the American Society of Hematology's annual meeting.
   Similar news · Read more »
   
3. Drug-based on MGH discovery may significantly improve treatment of dangerous blood disorder
   01-31-2008 · EurekAlert!
   Two clinical trials of the novel drug romiplostim show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura, a hematologic disorder that can cause uncontrolled bleeding. An international research team reports Phase 3 trial results for the drug, which duplicates the action of a natural hormone discovered by a Massachusetts General Hospital investigator, in the Feb. 2 issue of The Lancet.
   Similar news · Read more »
   
4. Promising Antiobesity Drug Fails To Produce Clinically Meaningful Weight Loss
   10-05-2006 · ScienceDaily
   A drug designed to target a powerful hunger-stimulating factor that has long been considered a prime target for antiobesity therapy failed to produce clinically meaningful weight loss in obese people in a long-term clinical trial. People taking the drug known as MK-0557 for a year consistently lost about three pounds more than those taking a placebo, researchers reported in the October issue of the journal Cell Metabolism, published by Cell Press.
   Similar news · Read more »
   
5. New data show ACTOS(r) (pioglitazone HCl) halted progression of atherosclerosis as indicated by CIMT
   11-13-2006 · EurekAlert!
   Researchers today presented data showing that ACTOS® (pioglitazone HCl) halted the progression of atherosclerosis as measured by carotid intima-media thickness (CIMT) in patients with type 2 diabetes. Results from the clinical trial, CHICAGO (Carotid intima-media tHICkness in Atherosclerosis using pioGlitazOne), are part of a late-breaker presentation at the American Heart Association's Scientific Sessions 2006, coincidentally being held in Chicago, and coincide with an early online issue of the Journal of the American Medical Association.
   Similar news · Read more »
   
6. Drug that chokes off tumor blood vessels offers new hope to lung cancer patients
   12-13-2006 · EurekAlert!
   Patients suffering from the most common type of lung cancer experienced a 20-percent improvement in overall survival in a national clinical trial of a drug that chokes off the blood vessels nourishing tumors, a multicenter study has found.
   Similar news · Read more »
   
7. Stanford study finds no conclusive benefit from treating kleptomania
   03-14-2007 · EurekAlert!
   A small clinical trial of a medication to treat kleptomania has failed to find any conclusive benefit for patients with the impulsive stealing disorder, according to researchers at the Stanford University School of Medicine
   Similar news · Read more »
   
8. First clinical trial of gene therapy for childhood blindness
   05-01-2007 · EurekAlert!
   The first clinical trial to test a revolutionary treatment for blindness in children has been announced by researchers at UCL (University College London). The trial, funded by the Department of Health, is the first of its kind and could have a significant impact on future treatments for eye disease.
   Similar news · Read more »
   
9. Infants with bronchiolitis may benefit more from albuterol
   05-16-2007 · EurekAlert!
   Bronchiolitis, a wheezing much like asthma in adults, is responsible for many hospital admissions of infants. There are two drugs in general use to treat this condition, epinephrine and albuterol, and there is some controversy and passion involved in the choice of medication. In a paper to be presented at the 2007 Society for Academic Emergency Medicine Annual Meeting, a double-blind randomized clinical trial involving over 700 infants showed a clear advantage for albuterol.
   Similar news · Read more »
   
10. University of Zurich announces worldwide clinical trial of Cardiac Resynchronization Therapy
    06-22-2007 · EurekAlert!
    University of Zurich announces initiation of a worldwide clinical trial to evaluate the impact of Cardiac Resynchronization Therapy in patients with heart failure and narrow QRS.
    Similar news · Read more »